Mechanism of neurooncogenesis by JC virus -- Relationship to human brain tumors.

JC 病毒的神经肿瘤发生机制——与人脑肿瘤的关系。

基本信息

项目摘要

A new human polyomavirus, JC virus, first isolated in Japan by us, has been shown to be highly neurooncogenic to hamsters, and was named JC virus Tokyo-1 strain (Abb: JCT). JCT has been shown to induce constantly mid-cerebellar neuroectodermal tumors in hamsters, which are very similar to human medulloblastoma. The host range of JCT was wide, and tumorgeniciy was very high, compared to those isolated from U.S.A. and West Germany. To investigate this unique properties of JCT, we cloned JCT-DNA, and examined the genomic characters of DNA.1. Origin of medulloblastoma: We cloned the T region of JCT-DNA, and labeled the antisence mRNA of JCT-T region with radioisotope, and examined JCT mRNA in the hamster cerebellum after inoculation by in situ hybridization. The mRNA was first detected in the cells of the cerebellar molecular layer between the external granular layer and the internal granular layer, as well as cells in the internal granular layer. Thus, it could be said that the cells in the developing external granular layer were infected with JCT, migrated into the internal granular layer carrying the integrated JCT genome, then express the phenotypic transformation in the internal granular layer.2. Difference of JCT in restriction enzyme cleavaged pattern: To compare the JCT to those from other countries, we cloned JCT DNA directly from the original PML brain as well as cultured cells. JCT has two cleavaged sites by Hinc II and Pvu II digestion, repectively, which were not described in the other strains. This seemed to be adventagious for JCT to widen the host range.3. Differences of regulatory gene of JCT: We examined the DNA sequences of the regulatory genes of JCT, and compared them with other JC viruses. JCT has 23-base pair insertion after TATA sequences. The insertion, which has not detected in the other , has a potential core sequence of the enhancer. Thus, the high oncogenicity of JCT may owe this insertion of enhancer DNA in its regulatory gene.
JC病毒是我们在日本首次分离到的一种新的人类多瘤病毒,对仓鼠具有高度的神经致瘤性,被命名为JC病毒东京1株(简称:JCT)。JCT已被证明在仓鼠中持续诱导小脑中神经外胚层肿瘤,其非常类似于人类髓母细胞瘤。与美国和德国分离株相比,JCT的宿主范围广,致瘤性高。为了研究JCT的这种独特性质,我们克隆了JCT-DNA,并检查了DNA的基因组特征。髓母细胞瘤的起源:我们克隆了JCT-DNA的T区,用放射性同位素标记了JCT-T区的反义mRNA,用原位杂交技术检测了接种后金黄地鼠小脑中JCTmRNA的表达。该mRNA首先在小脑外颗粒层和内颗粒层之间的分子层细胞以及内颗粒层细胞中检测到。因此,可以说发育中的外颗粒层细胞感染了JCT,携带整合的JCT基因组迁移到内颗粒层,然后在内颗粒层表达表型转化. JCT在限制性内切酶切割模式上的差异:为了将JCT与其他国家的JCT进行比较,我们直接从原始PML脑以及培养细胞中克隆了JCT DNA。JCT有两个被Hinc II和Pvu II消化的切割位点,这在其他菌株中没有描述。这似乎是冒险的JCT扩大主机范围。JCT病毒调控基因的差异:我们对JCT病毒调控基因的DNA序列进行了分析,并与其它JC病毒进行了比较。JCT在TATA序列之后具有23个碱基对插入。在另一个中未检测到的插入具有增强子的潜在核心序列。因此,JCT的高致瘤性可能是由于在其调节基因中插入了增强子DNA。

项目成果

期刊论文数量(22)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Nagashima,K.:"Progressive mulrifocal leukoencephalopathy and JC virus." Clin. Microbiol.13. 427-432 (1986)
Nagashima,K.:“进行性多灶性白质脑病和 JC 病毒。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
松田道行: 神経進歩. 30. 978-987 (1986)
松田道之:神经学进展。30. 978-987 (1986)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Matsuda,M.,: J.Natl.Cancer Inst.(1987)
松田,M.,:国家癌症研究所杂志(1987)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Matsuda,M.,: "Genetic characterization of JC virus Tokyo-1 strain, a variant oncogenic in rodents" Virua Res.7. - in press (1987)
Matsuda,M.,:“JC 病毒 Tokyo-1 株的遗传特征,这是一种啮齿类致癌变异体”Virua Res.7。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Nagashima,K.,: Prog.Neuropathol.6. 145-163 (1986)
Nagashima,K.,:Prog.Neuropathol.6。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

NAGASHIMA Kazuo其他文献

NAGASHIMA Kazuo的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('NAGASHIMA Kazuo', 18)}}的其他基金

Analysis of mechanisms of demyelination in progressive multifocal leukoencephalopathy
进行性多灶性白质脑病脱髓鞘机制分析
  • 批准号:
    10357002
  • 财政年份:
    1998
  • 资助金额:
    $ 3.14万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A).
Analysis of apoptotic mechanism of cerebellar granular cells
小脑颗粒细胞凋亡机制分析
  • 批准号:
    09470058
  • 财政年份:
    1997
  • 资助金额:
    $ 3.14万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Investigation of viral genome relating to human brain tumor using DNA amplification method
利用DNA扩增法研究与人脑肿瘤相关的病毒基因组
  • 批准号:
    02807036
  • 财政年份:
    1990
  • 资助金额:
    $ 3.14万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似海外基金

The role of ST6GAL2 and GM3 synthase dysregulation in the pathogenesis of Medulloblastoma. An in-vitro study.
ST6GAL2 和 GM3 合酶失调在髓母细胞瘤发病机制中的作用。
  • 批准号:
    24K19553
  • 财政年份:
    2024
  • 资助金额:
    $ 3.14万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Analysis of Paediatric Medulloblastoma cellular heterogeneity using Single-cell transcriptomic profiling for improved therapeutic strategies
使用单细胞转录组分析分析儿科髓母细胞瘤细胞异质性以改进治疗策略
  • 批准号:
    2882274
  • 财政年份:
    2023
  • 资助金额:
    $ 3.14万
  • 项目类别:
    Studentship
Oncogenic mechanisms underlying GLI2-amplified medulloblastoma
GLI2扩增的髓母细胞瘤的致癌机制
  • 批准号:
    10561373
  • 财政年份:
    2023
  • 资助金额:
    $ 3.14万
  • 项目类别:
Prospective international phase-III study to improve neurocognitive outcomes in young children with low-risk medulloblastoma (YCMB-LR)
改善低危髓母细胞瘤幼儿神经认知结果的前瞻性国际 III 期研究 (YCMB-LR)
  • 批准号:
    10720110
  • 财政年份:
    2023
  • 资助金额:
    $ 3.14万
  • 项目类别:
The Role of GABA Transaminase ABAT in Pediatric Brain Tumor Medulloblastoma Development and Spread
GABA 转氨酶 ABAT 在小儿脑肿瘤髓母细胞瘤发展和扩散中的作用
  • 批准号:
    10716956
  • 财政年份:
    2023
  • 资助金额:
    $ 3.14万
  • 项目类别:
Defining a targetable mechano-metastatic cascade to treat medulloblastoma metastasis
定义可靶向的机械转移级联来治疗髓母细胞瘤转移
  • 批准号:
    488101
  • 财政年份:
    2023
  • 资助金额:
    $ 3.14万
  • 项目类别:
    Operating Grants
Investigation of ecDNA as a driver of intratumoral heterogeneity and treatment resistance in high-risk medulloblastoma
EcDNA 作为高危髓母细胞瘤瘤内异质性和治疗耐药性驱动因素的研究
  • 批准号:
    10709196
  • 财政年份:
    2023
  • 资助金额:
    $ 3.14万
  • 项目类别:
Developmental cellular origins of pediatric medulloblastoma
儿童髓母细胞瘤的发育细胞起源
  • 批准号:
    488211
  • 财政年份:
    2023
  • 资助金额:
    $ 3.14万
  • 项目类别:
    Operating Grants
Enabling immunotherapy for high-risk Group 3 medulloblastoma via systems immunology
通过系统免疫学对高危 3 组髓母细胞瘤进行免疫治疗
  • 批准号:
    10714138
  • 财政年份:
    2023
  • 资助金额:
    $ 3.14万
  • 项目类别:
Naturally Targeted Exosomal TLR7/8 Agonist for Immunotherapy of Medulloblastoma
用于髓母细胞瘤免疫治疗的天然靶向外泌体 TLR7/8 激动剂
  • 批准号:
    10790660
  • 财政年份:
    2023
  • 资助金额:
    $ 3.14万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了